Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (CIT-03)
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2014
At a glance
- Drugs Gusperimus (Primary) ; Antithymocyte globulin; Basiliximab; Daclizumab; Etanercept; Sirolimus; Tacrolimus
- Indications Islet cell transplant rejection
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 16 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Sep 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2014 as reported by ClinicalTrials.gov.